RSCM
AGL icon

Rock Springs Capital Management’s Agilon Health AGL Stock Holding History

Rock Springs Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.1M Buy
262,600
+2,600
+1% +$170K 1.37% 18
2026
Q1 		$2.06M Hold
260,000
– – 0.12% 89
2025
Q4 		$4.48M Sell
260,000
-18,652
-7% -$362K 0.23% 71
2025
Q3 		$7.18M Buy
278,652
+16,636
+6% +$628K 0.42% 58
2025
Q2 		$15.1M Sell
262,016
-15,984
-6% -$1.28M 0.94% 38
2025
Q1 		$30.1M Sell
278,000
-20,532
-7% -$1.79M 1.72% 21
2024
Q4 		$14.2M Sell
298,532
-65,340
-18% -$3.95M 0.54% 55
2024
Q3 		$35.8M Buy
363,872
+7,872
+2% +$1.02M 1.16% 34
2024
Q2 		$58.2M Buy
356,000
+2,600
+0.7% +$370K 1.75% 17
2024
Q1 		$53.9M Buy
353,400
+8,200
+2% +$1.36M 1.37% 27
2023
Q4 		$108M Buy
345,200
+13,500
+4% +$4.89M 2.67% 10
2023
Q3 		$147M Buy
331,700
+400
+0.1% +$181K 3.95% 3
2023
Q2 		$144M Buy
331,300
+16,000
+5% +$8.99M 3.42% 4
2023
Q1 		$187M Buy
315,300
+400
+0.1% +$224K 4.47% 2
2022
Q4 		$127M Buy
314,900
+5,000
+2% +$2.34M 3.06% 7
2022
Q3 		$181M Buy
309,900
+2,660
+0.9% +$1.59M 4.69% 2
2022
Q2 		$168M Buy
307,240
+1,640
+0.5% +$829K 4.88% 2
2022
Q1 		$194M Buy
305,600
+5,800
+2% +$2.99M 4.88% 1
2021
Q4 		$202M Buy
299,800
+16,800
+6% +$10.2M 4.68% 1
2021
Q3 		$185M Buy
283,000
+3,039
+1% +$2.6M 3.9% 1
2021
Q2 		$284M Buy
+279,961
New +$245M 5.61% 1

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rock Springs Capital Management's AGL Position: Q2 2026 in Review

Rock Springs Capital Management increased its Agilon Health (AGL) stake by 1% in Q2 2026, buying an estimated $170K and bringing the position to 262,600 shares worth $28.1M. The position accounts for 1.37% of the portfolio, ranked #18.

Rock Springs Capital Management first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $284M in Q2 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Rock Springs Capital Management held 262,600 shares of Agilon Health worth $28.1M as of Q2 2026.
  • Rock Springs Capital Management bought 2,600 Agilon Health shares in Q2 2026, an estimated $170K.
  • Agilon Health made up 1.37% of Rock Springs Capital Management's portfolio in Q2 2026, its #18 holding.
  • Rock Springs Capital Management first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Rock Springs Capital Management's Agilon Health position peaked at $284M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.